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Reactive species are compounds related to two types of
molecules, the reactive oxygen species and the reactive nitro-
gen species. These compounds are produced in the normal
metabolism of cells and may take part in the pathological
process named oxidative stress, which is promoted when
the balance between free radicals and antioxidants tends to
favour the former. As a result, the excess of free radicals
within the human body leads to oxidative stress, resulting
in the development or potentiation of many types of diseases,
namely, chronic disorders, cardiovascular problems, diabe-
tes, cancer, and rheumatoid arthritis [1].
A few decades ago, the belief regarding free radicals
and oxidative stress was that they were completely unde-
sired and dangerous for the human body and needed to
be removed from our bodies immediately after their for-
mation, either through endogenous or exogenous (diet)
antioxidants. Today, this demonizing view has mellowed
down and it is known that oxidative stress is part of the
innate human immune system, and that free radicals are
also related to defence mechanisms, but also used as cell
mediators, pathway signalling, cell differentiation, prolifer-
ation and migration inducers, and release or inactivate
the endothelium-derived relaxing factor, among other pro-
cesses [1, 2].
The aim of this special edition is to shed some light on the
effects of antioxidants and prooxidants on diseases and their
overall impact on aging, following the free radical theory of
aging. The initial focus of aging was centred on the free rad-
ical damage to macromolecules; however, it has become clear
that hydroperoxides like H2O2 play important roles in phys-
iologic signalling. Thus, the dichotomy resides on the fact
that alterations in redox signalling are observed in aging,
but, on the other hand, deviation from redux homeostasis
can result in disease, making the study of redox signalling a
hot topic. Furthermore, the free radical theory of aging has
been threatened after recent discoveries on the importance
of hydroperoxides and other radicals in the human body.
Many scientists claim that it is should not be considered a
single theory, but a part of a wider general theory of aging
[3, 4]. Despite the free radical theory of aging being ques-
tioned, the link between free radicals, oxidative stress, and
many diseases is scientifically proven. Examples of these
diseases are neurodegenerative ones, which, with increasing
life expectancy will also increase in the coming decades.
New and unusual methods are being tested for these types
of diseases, namely, by fine-tuning antioxidant concentra-
tions, exhaustive study of antioxidant mechanisms and
interactions, modulation of oxidative stress, and other ther-
apeutic approaches [5–7].
This special edition, comprised of 9 original research
articles and 4 reviews on various aspects, namely, pro and
antioxidant functions of the peroxisome-mitochondria con-
nection and its impact on aging and disease, the impact of
oxidative stress on the regeneration of pancreatic beta cells,
the impact of metallothionein in brain disorders, and finally
an extensive overview of the role of flavonoids as putative
inducers of transcription factors Nrf2, FoxO, and PPARγ.
In terms of research manuscripts, four of these describe the
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role of specific plant compounds in the human body or in test
subjects (mice and rats), namely, the cardioprotective effects
of salvianic acid A and raloxifene in mice with elevated
homocysteine and estrogen-deficient rats, respectively.
The effects of berberine as preconditioning agent to reduce
premature senescence of cells were also researched, as well
as the effect of resveratrol on rats’ cognitive performance
with aging. Plant extracts were also described as having
cardioprotective effects and reducing oxidative stress, while
the in vitro antioxidant and antifibrotic profile of other
herbal formulations was tested. Dietary supplements, com-
monly reported as being effective against many neurode-
generative diseases and having antioxidant activity, were
also tested in terms of quality control by liquid chroma-
tography with the aid of a mass spectrometer. Finally,
using new agar diffusion methods, the risk of tumors
was evaluated through the measurement of urinary and
serumal antioxidants.
The editors hope that the published articles of this special
edition may be of interest to all readers, and overall, be of aid
to further improve the research on free radicals, antioxidants
and prooxidants, aging, and related diseases.
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